- Home
- SHMD vs MIST Comparison
SHMD vs MIST Comparison
Compare SHMD & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHMD
- MIST
- Stock Information
- Founded
- SHMD 1864
- MIST 2003
- Country
- SHMD Germany
- MIST Canada
- Employees
- SHMD N/A
- MIST N/A
- Industry
- SHMD
- MIST Biotechnology: Pharmaceutical Preparations
- Sector
- SHMD
- MIST Health Care
- Exchange
- SHMD Nasdaq
- MIST Nasdaq
- Market Cap
- SHMD 124.9M
- MIST 145.3M
- IPO Year
- SHMD N/A
- MIST N/A
- Fundamental
- Price
- SHMD $4.32
- MIST $1.94
- Analyst Decision
- SHMD
- MIST Strong Buy
- Analyst Count
- SHMD 0
- MIST 3
- Target Price
- SHMD N/A
- MIST $6.33
- AVG Volume (30 Days)
- SHMD 90.8K
- MIST 1.3M
- Earning Date
- SHMD 01-01-0001
- MIST 11-11-2025
- Dividend Yield
- SHMD N/A
- MIST N/A
- EPS Growth
- SHMD N/A
- MIST N/A
- EPS
- SHMD N/A
- MIST N/A
- Revenue
- SHMD $85,165,542.00
- MIST N/A
- Revenue This Year
- SHMD N/A
- MIST N/A
- Revenue Next Year
- SHMD N/A
- MIST N/A
- P/E Ratio
- SHMD N/A
- MIST N/A
- Revenue Growth
- SHMD N/A
- MIST N/A
- 52 Week Low
- SHMD $1.86
- MIST $0.63
- 52 Week High
- SHMD $4.50
- MIST $2.75
- Technical
- Relative Strength Index (RSI)
- SHMD 70.83
- MIST 47.75
- Support Level
- SHMD $2.43
- MIST $1.96
- Resistance Level
- SHMD $3.34
- MIST $2.14
- Average True Range (ATR)
- SHMD 0.54
- MIST 0.12
- MACD
- SHMD 0.15
- MIST -0.02
- Stochastic Oscillator
- SHMD 91.65
- MIST 6.67
About SHMD SCHMID Group N.V. Class A Ordinary Shares
Schmid Group NV is a global supplier of equipment, software and services for various industries such as printed circuit board (PCB), substrate manufacturing, photovoltaics, and glass and energy storage with a focus on the highest end of this market in terms of technology and performance. It focuses on a modular product portfolio of machinery to use in the manufacturing of high-end PCB equipment and semiconductor packaging devices which includes common flexible circuit fabrication techniques such as subtractive, semi-additive processes (SAP) and modified semi-additive processes (mSAP).
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).